Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Prospective Post Market Clinical Follow-up Study of the Zimmer Trabecular Metal Reverse Should System Used in Primary or Revision Reverse Total Shoulder Arthroplasty

NCT01480440 is registered in ClinicalTrials.gov with Zimmer Biomet as lead sponsor.

NCT NCT01480440
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01480440 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Prospective Post Market Clinical Follow-up Study of the Zimmer Trabecular Metal Reverse Should System Used in Primary or Revision Reverse Total Shoulder Arthroplasty
Lead sponsor
Zimmer Biomet
Phase
Observational
Overall status
Active, not recruiting
Start date
January 31, 2011
Completion date
December 31, 2026
Enrollment
200 (estimated)
Sites
5

Conditions

As the registry lists them; a condition with its own page is linked.

avascular necrosis, gross rotator cuff deficiency, irreducible 3-and 4-part proximal humeral fractures, osteoarthritis, post-traumatic arthritis, revision total shoulder arthroplasty, rheumatoid arthritis, ununited humeral head fracture